LONDON, Dec 6: Britain is preparing to become the first country to roll out the Pfizer/BioNTech COVID-19 vaccine this week, initially making the shot available at hospitals before distributing stocks to doctors’ clinics, the government said on Sunday.

LAHAN, Dec 4: The Facebook pages of the Chief Minister (CM) of Province 2 Lalbabu Raut were hacked on Friday morning.

LONDON, Dec 3: Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech COVID-19 vaccine for use and said that it will be rolled out from early next week.

Q&A: Where are we in the COVID-19 vaccine race?

Published On: November 30, 2020 07:33 PM NPT By: Reuters

Large global trials of several COVID-19 vaccine candidates involving tens of thousands of participants are well underway with some having gathered sufficient data to seek emergency use authorisation.

AstraZeneca COVID-19 vaccine can be 90% effective, results show

Published On: November 23, 2020 01:17 PM NPT By: Reuters

LONDON, Nov 23:  AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.

Moderna to charge $25-$37 for COVID-19 vaccine: CEO tells paper

Published On: November 22, 2020 01:40 PM NPT By: Reuters

FRANKFURT, Nov 22: Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

WHO suspends remdesivir from list of medicines

Published On: November 21, 2020 12:09 PM NPT By: Reuters

GENEVA, Nov 21: The World Health Organization said on Friday it has suspended Gilead’s remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised COVID-19 patients.

Pfizer to submit U.S. emergency use application for COVID-19 vaccine

Published On: November 20, 2020 06:49 PM NPT By: Reuters

NEW YORK, Nov 20: Pfizer Inc said it will apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.

Oxford scientists expect COVID-19 vaccine data by Christmas

Published On: November 19, 2020 07:35 PM NPT By: Associated Press

LONDON, Nov 19:  University of Oxford scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas, a key researcher said Thursday as he discussed the team’s latest findings.

Moderna says its vaccine is 94.5% effective in preventing COVID-19

Published On: November 17, 2020 08:30 AM NPT By: Reuters

MASSACHUSETTS, Nov 17: Moderna Inc’s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.